What are peptides, are they safe and is there evidence to back up the hype? – theguardian.com
Peptides are trending in wellness circles, but experts warn the evidence supporting many claims remains limited and safety questions persist.
Peptides are trending in wellness circles, but experts warn the evidence supporting many claims remains limited and safety questions persist.
A physician’s patient choosing peptides over proven statins reveals medicine’s struggle with wellness culture influence.
A new oral GLP-1 medication overcomes needle anxiety barriers, potentially expanding access to weight loss and diabetes treatment.
Plus-size fashion advocates worry that widespread GLP-1 use for weight loss could prompt retailers to reduce clothing options for larger bodies.
FDA warns of rare serious liver injury with Veozah for menopausal hot flashes; patients should stop medication if liver symptoms appear.
FDA approves Eli Lilly’s oral GLP-1 pill, offering the first non-injectable option for diabetes and weight management treatment.
FDA approves new oral GLP-1 medication for weight loss, expanding treatment options beyond injectable formulations.
HRT may help preserve skin collagen and thickness during menopause when estrogen decline accelerates skin aging, according to Physician’s Weekly.
McKinney clinic introduces peptide therapy services as demand grows for anti-aging and wellness treatments.
Nebraska Medicine clarifies HRT cancer risks, noting benefits often outweigh concerns for appropriately selected women experiencing menopause.